Development of the metanephric kidney is an experimental model system to analyze interactions between mesenchymal and epithelial cells and mesenchymal-epithelial transition. To study the underlying genetic mechanisms we employed organ culture and differential display PCR to identify genes regulated upon induction of mesenchymal cells. One of the genes found encodes the secreted frizzled related protein 2 (sFRP2) that is upregulated within 2 days of in vitro development. In vivo sFRP2 expression was likewise found in mesenchymal condensates and subsequent epithelial structures. Detailed in situ hybridization analysis revealed sFRP2 expression during development of the eye, brain, neural tube, craniofacial mesenchyme, joints, testis, pancreas and below the epithelia of oesophagus, aorta and ureter where smooth muscles develop. In a comparative analysis transcripts of the related sFRP1 and sFRP4 genes were frequently found in the same tissues as sFRP2 with their expression domains overlapping in some instances, but mutually exclusive in others. While sFRP1 is specifically expressed in the embryonic metanephros, eye, brain, teeth, salivary gland and small intestine, there is only weak expression of sFRP4 except for the developing teeth, eye and salivary gland. The interpretation of the highly specific spatial and temporal expression patterns of sFRP genes will partly depend on a better functional understanding of the interaction between wnt, fz and sFRP family members. Nevertheless, sFRP genes must play quite distinct roles in the morphogenesis of several organ systems.
Introduction
Multicellular organisms develop through the concerted interaction of cells and tissues and a series of inductive processes. In many organs epithelial sheets develop and branch as a result of epithelial-mesenchymal interaction. In some tissues these epithelia derive directly from an epithelial bud that grows and branches into the mesenchyme, as can be observed in the development of the lung, salivary gland, mammary gland and pancreas. In the mammalian metanephros the tubules of the collecting system evolve by this process, whereas the epithelial nephrons develop from the metanephrogenic mesenchyme by mesenchymal-epithelial transition. The molecular analysis of the latter provided the starting point of the present report.
Development of the permanent kidney in the mouse begins at E10.5 with the outgrowth of the ureteric bud from the Wolffian duct. Upon contact with the metanephrogenic mesenchyme at E11.0 the bud is induced to branch. Signals from these branched bud tips then induce the surrounding mesenchyme to condense. These condensates epithelialize and elongate into comma-and S-shaped bodies, which subsequently develop into nephrons.
Although unraveling the regulatory network underlying these processes is far from complete, many signaling molecules, their receptors and transcriptional regulators have been identified in recent years (Bard et al., 1994) . It becomes increasingly evident that the same molecules and signaling cascades are involved in the development of multiple other tissues and organs.
One class of signaling molecules implicated in these processes are the mammalian homologues of the Drosophila wingless gene, the wnt genes. More than fifteen wnt genes have been identified in the mouse and many of them have clearly been shown to represent important signaling molecules during early embryogenesis and organogenesis (for review see Cadigan and Nusse, 1997) . In the developing kidney three of these secreted glycoproteins are expressed: Wnt-4, -7b and -11. Wnt-4 is expressed in the condensed metanephrogenic mesenchyme and its derivatives, the comma-and S-shaped bodies. Targeted disruption of wnt-4 in mice resulted in a failure to form pretubular aggregates demonstrating its importance for nephrogenesis (Stark et al., 1994) . Wnt-7b is expressed in the epithelium of the collecting system including the ureter stalk while wnt-11 is restricted to the tips of the branching ureter (Kispert et al., 1996) .
Homologues of the Drosophila frizzled proteins are likely to act as transmembrane receptors for Wnt signaling molecules. They consist of an extracellular cysteine-rich domain (CRD) responsible for wnt-binding, seven transmembrane domains and a highly variable cytoplasmic tail (Bhanot et al., 1996; Wang et al., 1996; Yang-Snyder et al., 1996) .
More recently, related molecules containing the CRD motif but lacking the transmembrane-spanning domains of frizzled (the secreted frizzled related proteins) have been identified (Finch et al., 1997; Leyns et al., 1997; Rattner et al., 1997; Shirozu et al., 1996; Wang et al., 1997) . The respective genes have been isolated from different species through various approaches, e.g. homology screening or searches for apoptosis related genes. The first was Xenopus frzb-1, originally named frezzled, which was identified in a screen for cDNAs enriched in the Spemann organizer (Bouwmeester et al., 1996) . Its mammalian homologues have been cloned and characterized, including a detailed analysis of expression during mouse development (Hoang et al., 1996; Mayr et al., 1997; Wang et al., 1997) .
In several studies it was shown that secreted frizzled related proteins bind to wingless or some of the vertebrate counterparts in vitro Rattner et al., 1997) . At least for frz-b an antagonistic action through binding to XWnt-8 has been reported (Leyns et al., 1997; Wang et al., 1997) . However, it is not clear, whether all sFRPs act to down-regulate wnt function and how specific these interactions are. In a screen to isolate genes regulated in the early events of kidney mesenchymal induction we identified sFRP2 in in vitro induced mesenchyme. sFRP2 expression was analysed during several stages of murine postimplantation development and compared to that of the related sFRP1 and sFRP4 genes. In addition to the developing kidney all sFRP genes were found to be expressed at multiple sites of epithelial-mesenchymal interaction. The highly specific and dynamic expression pattern of these genes suggests that they have the potential to be involved in several developmental decision processes.
Results

Induction of sFRP2 in transfilter cultures
To identify genes differentially expressed upon induction of the metanephrogenic mesenchyme, we compared cDNA from uninduced and induced mesenchymal blastema using differential display PCR (ddPCR). Kidney anlagen were dissected from mouse embryos at E11.0 and ureteric buds were removed. These mesenchymal cells were incubated for 1, 2 or 3 days with dorsal spinal cord as a heterologous inducer (Grobstein, 1956 ) on opposite sides of Millipore CM filters. After 1 day of in vitro development mesenchymal condensates were visible and after 2-3 days the entire culture was transformed into polarized epithelial structures (data not shown).
Total RNAs prepared from mesenchymes were analysed by ddPCR using 240 different primer combinations. One of the PCR products showing increased intensity after 2 days of in vitro development turned out to be derived from the gene encoding the secreted frizzled related protein 2 (sFRP2, Fig. 1A ). Northern blot analysis with a sFRP2 probe revealed expression of the corresponding 2 kb transcript in RNA from cultures induced for 2 and 3 days but not from uninduced mesenchyme (Fig. 1B) .
Expression of sFRP2 in the developing meso-and metanephros
Since the sFRP2 gene is induced in the metanephrogenic mesenchyme during in vitro development, we performed in situ hybridization to assess its expression in vivo. During vertebrate development, three kinds of kidneys are formed: pro-, meso-and metanephros. While they differ in diversity of cell types and complexity the nephron is the basic functional unit of all three structures (Saxen, 1987) . As shown by in situ hybridization of whole-mount embryos and in transverse sections ( Fig. 2A,B) , sFRP2 is already expressed in the mesonephric kidney. It is first detected at E9.5 in the cranial (Fig. 4K ) and 1 day later in all mesonephric tubules ( Fig. 2A) . The Wolffian duct, however, does not express sFRP2 (Fig. 2B) . We next examined the expression of sFRP2 mRNA in the developing metanephric kidney from E12.5 up to the newborn stage (P0). sFRP2 transcripts were localized predominantly in condensing and epithelializing metanephrogenic mesenchyme (Fig. 2C-F) , while the ureter and its branches were negative. Specifically, sFRP2 is expressed in the mesenchymal condensates at the tips of the ureteric buds, in the comma-and S-shaped bodies. After E15.5 sFRP2 expression is confined to the glomerular precursors of the outer cortical region but missing in the inner part of the developing kidney where tubuli and mature glo-meruli are located (Fig. 2F) , suggesting that sFRP2 is involved in early differentiation of the nephric glomeruli, but not in the later events of tubule elongation and podocyte maturation. This is consistent with the fact that sFRP2 expression is only barely detectable in adult kidneys by Northern blot analysis (data not shown).
In addition to the early and intermediate glomerular precursors, a strong signal was observed in cells immediately surrounding the epithelium of the ureter stalk throughout its length during all stages analysed (Fig. 2D) .
Expression of other sFRP family members in the developing kidney
The sFRP2 gene is part of a larger gene family raising the question whether these genes have redundant functions and expression characteristics. Comparison of all publicly available sequences revealed that there are at least seven different members in this family (Fig. 3) . Three of these have only been cloned in other species, i.e. chicken (crescent), Xenopus (sizzled) or human (sarp3) and there are no murine counterparts available. Probes for three additional genes, sFRP1, -3 and -4, were available for comparative expression analysis. Results obtained for sFRP3 are consistent with previously published work and will not be presented here (see Section 3 for details). There have been no detailed studies on the expression of sFRP1 and 4 during development to date.
Northern blot and RNase protection analysis by Rattner et al. (1997) had shown that sFRP1 and sFRP4 are expressed in adult murine kidneys. To study the relationship between the expression patterns of these genes during kidney development in situ hybridization was performed on paraffin sections of fetal kidneys.
Starting at E13.5 sFRP1 signals are discernible in the periphery of the metanephros and surrounding the ureteric and nephrogenic tubules (Fig. 2G ). Similar expression patterns have been reported for the winged helix transcription factor BF-2 and the mesenchymal matrix protein tenascin that are restricted to the stromal cell lineage (Aufderheide et al., 1987; Hatini et al., 1996) . Following induction, only part of the mesenchyme condenses to form epithelia, whereas the remaining stem cells give rise to interstitial cells of the kidney stroma. The role of this cell lineage is poorly characterized but targeted disruption of BF-2 revealed an essential function in mesenchyme epithelium transition and branching of the ureter. In contrast to BF-2 and tenascin, however, sFRP1 expression in these outer cortical cells declines after E14.5 and instead becomes visible in the tubular parts of the nephron. Starting at E15.5, sFRP1 mRNA is strongly expressed in the future loops of Henle (Fig. 2H) . Thus, sFRP1 expression switches from the cells of the kidney stroma to the nephric tubules during their proliferation and early differentiation.
Localization of sFRP4 mRNA transcripts turned out to be more difficult because of its weak expression. In the kidney the gene appears to be transcribed in the condensing metanephrogenic mesenchyme (Fig. 2I ), but this was only evident after prolonged staining of sections. (0) and triplicates of induced mesenchymes cultured for 1, 2 and 3 days (1, 2, 3) were separated on a denaturing polyacrylamide gel. Primers used for reverse transcription and PCR were K and 04 (GCGCAAGCT 12 AA and CGGGAAGCTTGTGAC-CATTGCA). One of the cDNA fragments upregulated in the induced mesenchyme after 2 days of culture turned out to be identical to the sFRP2 gene. (B) Northern blot analysis of sFRP2 mRNA expression. Total RNA was prepared from uninduced metanephrogenic mesenchymes and induced mesenchymes cultured for 1, 2 or 3 days. Approximately 0.3-0.6 mg of each RNA was run on a 1.2% agarose-formaldehyde gel and total RNA loading was visualized by ethidium bromide staining. The gel was blotted and hybridized with a probe corresponding to 1 kb (starting at nucleotide 445) of the sFRP2 cDNA. Note that the 2 kb sFRP2 transcript is only detectable in the induced mesenchyme after 2 or more days of in vitro development.
Expression of sFRP genes in the CNS
As evident in whole-mount embryos, sFRP1 and sFRP2 are expressed in the forebrain and hindbrain, while only sFRP2 is also found in the neural tube. At E8.0 sFRP1 transcripts are very prominent in the future forebrain and in the ventral portion of the presumptive hindbrain, where the staining extends dorsally along the midbrain-hindbrain boundary (Fig. 4A) . By 8.5 days, sFRP1 expression in these tissues is maintained and a strong signal can be observed in rhombomere 4 (Fig. 4B ), which was confirmed by flatmount preparation of the hindbrain (not shown). sFRP1 mRNA can be detected in the hindbrain of whole-mount embryos until E11.5, ventral to the sFRP2 expression domains. At E9.5 and E10.5 sFRP1 is additionally expressed in the nasal placode ( Fig. 4C ,E) and the epibranchial placodes (white arrowheads in Fig. 4C ,F), giving rise to the olfactory epithelium and the cranial ganglia respectively. Later sFRP1 transcripts are also found in the matured derivatives of these ectodermal placodes see below. In the forebrain sFRP1 expression is initially confined to the prosencephalon ( Fig.  4A-D) and then to the telencephalic vesicle ( Fig. 4E-H) , where it remains strong until E15.5, the last stage analysed. At that point sFRP1 is expressed throughout the brain and Fig. 2 . Expression of sFRP genes during urogenital development. sFRP2 gene expression in the mesonephric tubules was detected by hybridization of E10.5 whole-mount embryos and transverse sections (arrowheads in (A) and (B)); the Wolffian duct is not stained (arrows in (B)). In the developing metanephric kidney at E12.5 (C,D) sFRP2 is strongly expressed in the comma-shaped bodies (C) and surrounding the ureter stalk (D), whereas the epithelium of the ureter itself and its branches are negative. (E) High magnification view of part of a E14.5 kidney, showing sFRP2 expression in the S-shaped bodies. At E15.5 (F) the staining is confined to the glomerular precursors, i.e. the comma-and S-shaped bodies of the outer cortical region. SFRP1 is expressed in the stromal cells of the kidney and in the adrenal cortex at E13.5 (G). At E15.5 (H) a strong sFRP1 signal is observed in the primitive loops of Henle (arrows). sFRP4 is weakly expressed in the condensing and epithelialized mesenchyme at E14.0 (I) but was only detectable after prolonged staining. Abbreviations: ac, adrenal cortex; cb, comma-shaped body; cm, condensing mesenchyme; da, dorsal aorta; k, kidney; nt, neural tube; sb, S-shaped body; u, ureter; us, ureter stalk. Scale bars, 100 mm. (C-I) are sagittal sections. the ganglia, but transcripts are only found in specific cell populations as indicated by the dotted staining pattern (Fig.  7A) .
In comparison to sFRP1, sFRP2 expression in the presumptive hindbrain extends dorsally, where it is more prominent in the odd-numbered rhombomeres ( Fig. 4I-P) . At day 10.5 sFRP2 is expressed in two longitudinal stripes (one in the basal and one in the alar plate; Fig. 4M ,N). The signal is located within the rhombomeres, whereas rhombomere boundaries do not express the gene. Additionally, sFRP2 is expressed in the diencephalon in a similar segmented pattern. According to the neuromeric model of the forebrain (Puelles and Rubenstein, 1993) these signals are located in the first two prosomeres (Fig. 4M,N) . The CNS of vertebrates is only transiently segmented and with the disappearance of transverse boundaries sFRP2 transcription also regresses. In the hindbrain, its expression remains strong at E11.5 in the basal plate, whereas it becomes restricted to a thin stripe in the alar part (Fig. 4O) . At E12.5 sFRP2 expression narrows further to a short stretch in the caudal part of the rhombencephalic basal plate (Fig. 4P) , which continuously regresses towards the border between metencephalon and myelencephalon, where it remains detectable in sagittal sections at E15.5 (see later in Fig. 7B, arrow) . In the forebrain sFRP2 becomes restricted to the ventricular zone and the future cerebral cortex and it is not detected in the adult brain as tested by Northern blot analysis.
In the neural tube only sFRP2 is expressed from E8.0 on (Fig. 4I-M,Q,R) . In situ hybridization of transverse sections demonstrates that sFRP2 transcripts are restricted to the ventral half of the neural tube except the floorplate at E10.5 (Fig. 4Q) . At E14.5, sFRP2 expression is maintained in the ependymal layer of the spinal cord containing proliferating cells (Fig. 4R) .
There was no detectable neural sFRP4 expression in whole-mount in situ hybridization. On paraffin sections a weak general staining was seen, except for elevated levels in the future cerebral cortex at E14.5 (Fig. 7C ) and in the ventricular zone at E15.5 (data not shown).
Expression of sFRP genes in the developing eye
Whole-mount in situ hybridization identified expression of sFRP genes in several additional structures, the most obvious being the developing eye. In mice, eye development starts at E9.0 when the optic vesicles evaginate from the brain and contact the overlying head ectoderm. The latter thickens into the lens placode, which folds in to form the lens vesicle. Simultaneously, the optic vesicle invaginates to form a double-walled optic cup (E10.5). The inner layer differentiates into the neural, the outer into the pigmented retina.
Expression of sFRP2 is found in the optic placode at E9.0 (not shown) and subsequently in the optic vesicle at E9.5 as seen in whole-mount embryos (Fig. 4K) . By 10.5 days, sFRP2 transcripts are detected in the lens vesicle and the inner layer of the invaginating optic vesicle (Fig. 5E ). sFRP1 expression on the other hand seems to be confined to ectodermal cells overlying the dorsal part of the optic vesicle (Fig. 4C,F) . This almost complementary expression pattern of sFRP1 and sFRP2 persists in all later stages of eye development analysed. sFRP1 mRNA is found in the lens fiber cells and the future pigmented retina (Fig. 5B-D) . It remains strongly expressed in the pigmented retina until E15.5 and in the lens it becomes restricted to the anterior part of the lens fiber cells. While sFRP1 is not expressed in the anterior lens epithelium up to E14.5, it becomes very prominent in this cell layer at E15.5 (Fig. 5D ). In contrast, sFRP2 is strongly expressed in the anterior lens epithelium at E14.5 (Fig. 5G ), but decreases thereafter (Fig. 5H) . Additionally, sFRP2 transcripts are consistently detected in the prospective neural retina (Fig. 5E-H) .
At E12.5 and through subsequent stages sFRP4 expression is also detectable in a pattern similar to that of sFRP2 ( Fig. 5I-L ). In the neural retina an outer cell dense layer containing mitotically active neuroblasts and an inner cell layer composed of postmitotic ganglion cells can be distinguished by days 14.5 and 15.5. While sFRP4 is expressed in both layers, sFRP2 is confined to the outer proliferating cell population. Similar to the developing kidney, sFRP4 expression is much weaker and partially overlapping with that of sFRP2, whereas sFRP1 shows a complementary expression pattern. Fig. 3 . Phylogenetic tree of sFRP genes. All published members of the sFRP family of genes available in Genbank were compared using the ClustalX software. Other algorithms produced identical trees. Several of the genes were identified in multiple species (b, cow; c, chicken; h, human; m, mouse; r, rat; x, Xenopus). The tree shown was generated using gap exclusion and correction for multiple substitutions. In transverse sections sFRP2 expression is restricted to the ventral half of the neural tube at E10.5 (Q) and at E14.5 (R) to the ventral ependymal layer. Abbreviations: a, anterior; ap, alar plate; bc, branchial clefts; bp, basal plate; el, ependymal layer; fb, forebrain; hb, hindbrain; mn, mesonephros; np, nasal placode; nt, neural tube; op, optic placode, ot, otic vesicle; ov, optic vesicle; p, posterior; pr, prosomere; r, rhombencephalon; vw, ventral body wall. Scale bar, 100 mm.
Expression of sFRP2 at sites of joint development
Another site of strong sFRP2 hybridization in whole mount embryos was observed in the developing limb buds with the appearance of precartilaginous condensations. The expression profile of sFRP2 was followed until 15.5 days of gestation by parallel whole-mount and section in situ hybridization. The skeletal elements of the limbs develop from single condensations, which grow, branch and segment. Expression of sFRP2 is seen at the ends of these condensations in the forelimb at E11.5 (Fig. 6A) . At E12.5, sFRP2 expression was observed lateral to the separating tibia and fibula (data not shown). Since development of the forelimb is about half a day ahead compared to the hindlimb, it appears that in the foot and hand paddle sFRP2 mRNA is first located at the proximal end of the digits and then moves Fig. 5 . Expression of sFRP genes in the developing eye. sFRP1, sFRP2 and sFRP4 expression was analysed at E10.5 (A,E,I, transverse), E12.5 (B,F,J, sagittal), E14.5 (C,G,K, transverse) and E15.5 (D,H,L, sagittal). sFRP1 expression is detected in the future pigmented retina and the lens fiber cells starting at E12.5 (B-D). At E15.5 sFRP1 expression in the lens is restricted to the anterior part (D). sFRP2 is consistently expressed in the future neural retina (E-H) where it becomes confined to the outer neuroblast layer. sFRP2 transcripts are also detected in the lens vesicle at E10.5 (E) and in the anterior lens epithelium at E14.5 (G). At E15.5 (H) sFRP2 expression in the lens epithelium fades. sFRP4 expression patterns in the developing eye (I-L) are similar to that of sFRP2 except that it is found throughout the neural retina. Abbreviations: ae, anterior lens epithelium; lv, lens vesicle; lf, lens fibers; nb, neuroblast layer; nr, neural retina; pr, pigmented retina. Scale bars, 100 mm. distally along the digital rays (Fig. 6B) . With the progression of digital development, sFRP2 is temporarily expressed between the segmenting phalanges ( Fig. 6C-E,G) . The strongest signals are generally seen between the cartilaginous elements of the most distal separating phalanges while earlier sites of expression sustain low levels. Hybridization of paraffin sections revealed that sFRP2 is also expressed in the developing shoulder from day 11.5 onwards and later Fig. 7 . Overview of sFRP1 (A), sFRP2 (B) and sFRP4 (C) expression patterns in sagittal sections. Note the strong sFRP1 expression in the entire brain, ganglia, salivary gland, molar teeth and olfactory epithelium (E15.5; A). sFRP2 is generally detected surrounding cartilaginous and epithelial structures in the skull (E15.5; B). (D,E) High magnification view of the region surrounding the nasal cavity. Expression of sFRP1 in the olfactory epithelium (D) contrasts with sFRP2 expression surrounding epithelium and cartilage (E). Additional cranial expression sites are the cochlear ganglion (nerve processes) and the cochlear epithelium for sFRP1 at E15.5 (G) and the enamel epithelium of the molars for sFRP2 (E16.5; H). A strong sFRP4 signal is only seen surrounding the developing incisor tooth (E14.5; C). A high power magnification view of the lower incisor tooth is shown below (F). sFRP4 transcripts are also detected in the branching epithelium (arrows) of the salivary gland (I, transverse section). Abbreviations: ce, cochlear epithelium; cg, cochlear ganglion; e, epithelium; ee, enamel epithelium; g, ganglia; hl, hindlimb; it, incisor tooth; k, kidney; mc, Meckel's cartilage; mt, molar tooth; nc, nasal cavity; oe, olfactory epithelium; sg, salivary gland; wf, wisker follicles. Scale bars, 100 mm.
surrounding the developing carpals and metacarpals, which is more difficult to visualize in whole mount preparations (data not shown).
A similar expression pattern was observed in the developing joints between the ribs and the thoracic vertebrae as well as in the future sternocostal joints. During development of the latter, sFRP2 transcripts can be detected between the sternal bands and where the rib primordia contact the sternum (Fig. 6F) . Taken together these results suggest that sFRP2 expression accompanies the segmentation of the long bones and precedes joint development. Again, sFRP1 and sFRP4 are barely expressed in the developing limbs. Only at later stages sFRP1 hybridization signals are detected in the distal parts of the separating phalanges (data not shown).
sFRP gene expression at other sites of epitheliomesenchymal interactions
Since sFRP1 expression was observed in the nasal placodes in E9.5 whole-mount embryos (Fig. 4C) , the gene may participate in the development of the olfactory epithelium. This sensory epithelium originates from the nasal placodes, which invaginate, their cells proliferate and olfactory neurons differentiate. At E10.5 sFRP1 transcripts were found at the medial nasal processes (Fig. 4E) and thereafter in the anterior portion of the invaginating olfactory epithelium (data not shown). At E15.5 sFRP1 is expressed on the basal side of the nasal epithelium, where proliferating stem cells and neuronal precursors reside (Fig. 7D) . At this later stage sFRP1 and sFRP2 show a striking complementary expression, where sFRP2 is restricted to the craniofacial mesenchyme surrounding cartilaginous and epithelial elements (Fig. 7E) . Similar expression of sFRP2 in the pharyngeal mesenchyme can be detected already at E11.5 in the maxillary and mandibular component of the first branchial arch (data not shown) and subsequently in the loose mesenchyme surrounding cartilage and epithelia of the skull as well as the whisker follicles (Fig. 7B) .
Preliminary analysis of sFRP gene expression in the developing teeth revealed a striking signal with the sFRP4 probe. Although sFRP4 expression was very weak in most tissues analysed, a strong signal was observed at the developing incisor teeth at E14.5 (Fig. 7C,F ). Transcripts were localized in the mesenchyme of the dental follicle surrounding the enamel organ only at the early cap stage. sFRP1 and sFRP2 are also expressed in the developing teeth, with highest levels at E15.5 and 16.5 in the mesenchyme and the dental epithelium of the developing molars, respectively (Fig. 7A,H) .
In addition to tissues described in more detail, sFRP gene expression was found in various other structures. sFRP1 transcripts were detected in the ventral body wall (Fig.  4F) , in the mesenchyme derived adrenal cortex (Fig. 2G) , the cochlear epithelium (Fig. 7G ) and the branching epithelium of the salivary gland (Fig. 7A ). In the latter sFRP4 is coexpressed in a similar pattern, representing one of the strongest sFRP4 expression sites (Fig. 7I) . Furthermore, sFRP2 and sFRP4 are expressed in testis especially the testicular cords and the exocrine pancreas (not shown). Additional sFRP2 expression domains are found in the epithelium of the second and third pharyngeal cleft at E10.5 (Fig. 4M) . Quite interestingly, sFRP2 is expressed in the outer wall of the large arteries and the oesophagus, which is similar to the expression around the ureter epithelium (Fig. 8) . A comparable staining of subepithelial tissue that will form smooth muscle and submucosa is seen with the sFRP1 probe in the developing gut (Fig. 8A) .
Discussion
In a screen to identify genes regulated upon induction and differentiation of metanephrogenic mesenchyme we identified the sFRP2 gene. Upregulation of the gene could be verified by Northern hybridization using even small amounts of total RNA (Ͻ1 mg), indicating that sFRP2 is highly expressed in these induced and differentiating cells. Expression of sFRP2 during nephrogenesis was followed by 5 (B, transverse) , the ureter stalk at E15.5 (C, sagittal), the dorsal aorta and the ductus arteriosus at E14.5 (D, transverse). sFRP2 signal surrounding the oesophagus is only barely detectable at E14.5. Abbreviations: a, aorta; da, ductus arteriosus; dd, duodenum; mg, midgut; o, oesophagus; t, trachea; ue, ureter epithelium. Scale bars, 100 mm.
in situ hybridization of whole-mount embryos and paraffin sections, showing that the gene is expressed in the condensed metanephrogenic mesenchyme and more prominently in early epithelialized mesenchymal derivatives. Later, sFRP2 expression is restricted to the cortical region where nephrogenesis proceeds, but soon declines and is almost absent in the adult murine kidney. During early nephrogenesis proliferation of induced mesenchymal cells is coupled to differentiation processes. While the renal vesicle proliferates and elongates into a comma-shaped body, its original mesenchymal cells convert into an epithelial cell type which becomes apparent at the S-shape stage cell diversification (Saxen, 1987) . sFRP2 is expressed in these structures, but it is turned off at the onset of terminal differentiation suggesting that it is involved only in these early developmental processes where cells proliferate and take on their final fate.
Similarly, in the developing nervous system and the eye sFRP2 expression is found in territories containing highly mitotic cells. At E9.5 and E10.5, when the neural tube consists primarily of an actively proliferating ventricular zone, sFRP2 is expressed in the entire ventral half of this tissue except the floor plate. As the proliferating zone regresses into a thin ependymal layer surrounding the central hole, sFRP2 expression also becomes restricted to a ventral subset of these mitotic cells. During eye development sFRP2 transcripts are detected in the prospective neural retina, where expression again becomes confined to the outer cell layer of mitotically active cells. Thus, sFRP2 seems to be needed in many proliferating neural cells, but may not be compatible with their terminal differentiation.
A highly specific and dynamic expression pattern of sFRP2 was found at sites of joint development. It is temporarily expressed where joints will form either by splitting of skeletal precursors, e.g. in the limbs, or by contact of two originally separate skeletal precursors as in the synchondrial joints between ribs and sternum. The mouse growth differentiation factor 5 (GDF5) is expressed in a very similar pattern in the developing limbs and it is also found where the ribs contact the sternum (Storm and Kingsley, 1996) . This BMP-related molecule is responsible for the mouse brachypodism phenotype and was shown to be involved in the early development of synovial and synchondrial joints. Interestingly, GDF5 continues to be strongly expressed between all limb skeletal elements until E15.5, whereas sFRP2 expression declines in a proximo-distal order. Therefore, it is possible that sFRP2 is involved in regional specification and initial differentiation of joints while GDF5 serves to control subsequent stages and final maturation of actual joints.
Comparison of sFRP gene expression
There is significant diversity in the expression patterns of sFRP family members with partly overlapping and partly complementary expression domains suggesting that each sFRP gene may serve quite unique and non-redundant functions. The major sites of expression defined for these genes to date are: neuronal and sensory cells (eye, ear, brain, ganglia, olfactory epithelium), salivary gland, kidney and teeth for sFRP1; the embryonic brain, eye, head mesenchyme, kidney, joints, pancreas and testis for sFRP2; the somites, neural tube, head mesenchyme, ear, peripheral nervous system, limb buds, kidney, urogenital ridge, dorsal aorta and sites of ossification for sFRP3 as reported by Mayr et al. (1997) and the eye, kidney, testis, pancreas, salivary gland and the teeth for sFRP4.
Comparison of signal strength on sections and hybridization signals on Northern blots revealed substantial differences in expression levels. sFRP4 expression is very low in most tissues analysed and this result is not due to technical difficulties since a very strong sFRP4 signal was observed, e.g. surrounding the developing incisor teeth, in the salivary gland and in the developing eye. This is supported by 'in silico' expression analysis where most EST cDNA clones were not derived from major organs but from libraries of the cochlea, prostate and uterus.
The sharpest contrasts in expression domains were seen in the development of the eyes and the nasopharynx. sFRP1 and sFRP2 appear to be expressed in mutually exclusive cell types in the retina and the lens. A similarly sharp demarcating boundary is found between the sFRP1 and sFRP2 domains in the basal layer of the olfactory epithelium and the surrounding mesenchyme, respectively. These patterns may be of special relevance if sFRP genes should indeed create diffusion barriers for secreted wnt proteins.
Another intriguing site of sFRP gene expression is found in the walls of multiple tube-like structures. In the large arteries, the oesophagus and the ureter sFRP2 is expressed in the medial layer that forms smooth muscle, mixed with connective tissue. Similarly, sFRP1 is expressed in the walls of the gut below the epithelial cells. Thus, expression of sFRP genes seems to be a common theme in the development of the supportive and contractile compartment of multiple lumen containing structures, albeit relying on different sFRP family members.
sFRP genes and wnt-fz signaling
Any functional interpretation of the expression patterns observed will heavily rely on comparison with the corresponding patterns of wnt and fz family members since sFRP proteins may directly interact with the wnt-signal/ fz-receptor cascade. In mammals eight frizzled transmembrane receptors have been identified to date, but surprisingly little is known about their expression patterns. Expression of several Mfz genes has been investigated in E17.5 mouse embryos, but the resolution is not sufficient to support any comparative analysis .
For wnt genes knowledge of their expression patterns is more advanced, but still incomplete due to the large number of family members. In the kidney, transcripts of three wnt genes have been detected. Whereas wnt-7b and wnt-11 were found in the branching ureter, wnt-4 is expressed in the condensed metanephrogenic mesenchyme and the commaand S-shaped bodies (Stark et al., 1994) similar to sFRP2. The expression surrounding the ureter stalk, however, is unique to sFRP2. Wnt-7b on the other hand is expressed within the epithelium of the ureter stalk (Kispert et al., 1996) and may interact with adjacent sFRP2 expressing cells. Wnt-4 and sFRP2 are already coexpressed in the mesonephric tubules. In the neural tube transcripts of the two genes are located in neighbouring territories, however. While wnt-4 is expressed in the dorsal part of the neural tube and the floor plate, sFRP2 is located between these two areas and may overlap with wnt-7b expression (Parr et al., 1993) . To our knowledge no wnt gene is expressed in exactly the same or neighboring regions as sFRP2 and it is difficult at present to interpret the significance of overlapping or complementary temporal and spatial expression patterns of sFRP and wnt genes for the following reasons. First, it is not clear how specific wnt-sFRP interactions are and whether one type of sFRP protein can bind different wnt molecules, perhaps with differing affinities. Second, the physiological function of sFRP genes is not yet clear. Being secreted molecules they cannot transmit signals into a cell. There is evidence that expression of sFRP genes may passively block wnt signaling (Finch et al., 1997) . Nevertheless, it has not been ruled out that sFRP molecules may modulate wnt activity in an active manner by acting as a coreceptor for fz genes when expressed at correctly titrated levels. The definition of sFRP expression patterns in the present report will help to design new experimental approaches to test hypotheses about possible interactions of sFRPs with frizzled and wnt family genes in signaling processes.
Experimental procedures
Mice
CD1 embryos were used throughout this study (Charles River Laboratories). The morning of the vaginal plug was defined as embryonic day 0.5 (E0.5).
Organ culture and RNA preparation
Embryonic metanephric kidney anlagen and pieces of dorsal spinal cord were dissected from E11 embryos in L15 medium (Gibco). Kidney rudiments were then incubated for 15 min in dissociation medium (2.5% trypsin/ EDTA (Gibco), 10% pancreatin and 10 K units DNase I) and ureteric buds were removed using tungsten needles. Enzymatic digestion was stopped in Ham's F12 medium with 20% fetal calf serum (FCS). All mesenchymes obtained from one litter (between 20 and 40) were cultured with dorsal spinal cord as a heterologous inducer or frozen at −80°C for RNA extraction. For induction dorsal spinal cord from E11 mouse embryos was dissected, placed on a Millipore CM filter (0.4 mm pore size) and covered with a second filter on which the mesenchymes were mounted. Tissues were cultured at 37°C for 1, 2 or 3 days in Ham's F12 medium with GlutaMAX (Gibco) supplemented with 5% FCS. Cultured mesenchymes were scraped from the filter and collected at −80°C. Total RNA was prepared from mesenchymes with TRIzol Reagent (Gibco) following the manufacturers instructions. The yield of total RNA per culture or litter ranged from 500 ng to 6 mg.
Differential display PCR
First strand cDNA synthesis and differential display PCR were performed as described by (Linskens et al., 1995) with minor modifications (Thaete et al., 1998) . PCR fragments were cut from the dried gels, reamplified with the same primer combinations as used before, purified and sequenced using the SequiTherm Cycle Sequencing kit (Epicentre Technologies). All sequences were compared to Genbank databases using the GCG (Genetics Computer Group) BLAST software.
Northern blot analysis
To verify integrity of RNA preparations 1 ml of total RNA (300-600 ng) was subjected to electrophoresis in a 1.2% agarose/formaldehyde gel (Ausubel et al., 1998) and transferred to a nylon membrane. This Northern blot was then used for hybridization with a sFRP2 probe radiolabeled by random priming. For expression analysis in adult tissues blots with 10 mg total RNA per lane were used.
Whole-mount in situ hybridization
IMAGE cDNA clones (Lennon et al., 1996) containing sFRP1, sFRP2, sFRP3 or sFRP4, cDNA fragments (sFRP1: ID 575916, sFRP2: ID 536389 and ID 368879, sFRP3: ID 805986, sFRP4: ID 553533) were used to prepare digoxigenin-labeled riboprobes. Plasmids were linearized and transcribed with T3, T7 or SP6 RNA polymerase in the presence of digoxigenin-UTP (Boehringer Mannheim, Germany).
Whole-mount in situ hybridization was performed according to (Henrique et al., 1995) with modifications. Briefly, mouse embryos were dissected in PBS, fixed overnight at 4°C in 4% paraformaldehyd/phosphate-buffered saline (PFA/PBS), dehydrated in a methanol series and stored in 100% methanol at −20°C until needed. For in situ hybridization, embryos were rehydrated, bleached in 6% hydrogen peroxide, treated with 20 mg/ml proteinase K, refixed in 4% PFA/0.2% glutaraldehyde/PBS and per-meabilized with RIPA buffer (0.1% SDS, 150 mM sodium chloride, 1% NP40, 0.5% sodium desoxycholate, 1mM EDTA, 50 mM Tris-HCl pH 8). Hybridization was performed overnight at 70°C with approximately 0.1 mg/ml probe. Embryos were washed several times in hybridization buffer at 70°C, treated with 100 U/ml RNaseT1 and 20 mg/ ml RNase A for 1 h at 37°C and incubated with alkaline phosphatase-coupled anti-digoxigenin antibody (Boehringer Mannheim). Embryos were washed for 1-3 days with several changes of MABT (100 mM maleic acid, 150 mM sodium chloride, 0.1% Tween 20) and stained with BMpurple substrate. The reaction was stopped in 10 mM EDTA/PBS/0.1% Tween 20 and the embryos were again fixed in 4% PFA/PBS.
In situ hybridization on paraffin sections
Embryos of different stages were dissected in PBS and fixed overnight in 4% PFA/PBS. They were washed in PBS, dehydrated in a graded isopropanol series, infiltrated with chloroform and embedded in paraffin. Sections of 5 mm were mounted on polylysine coated slides (Menzel), dried over night at 37°C and stored at 4°C.
For RNA in situ hybridization sections were dewaxed in chloroform, rehydrated in a graded ethanol series, washed in PBS, refixed for 30 min in 4% PFA/PBS, digested with 10 mg/ml proteinase K for 10 min, washed and again fixed. After washing in PBS, 2× SSC and Tris/glycine buffer (0.1 M Tris-HCl, 0.1 M glycine), sections were hybridized with 0.1 mg/ml digoxygenin labeled probes in hybridization buffer (50% formamide, 1.3× SSC pH 5, 5 mM EDTA, 0.5% CHAPS, 100 mg/ml heparin, 0.2% Tween 20, 100 mg/ml yeast tRNA) for 16-20 h at 72°C under Parafilm in a 5× SSC humified chamber. Following hybridization, sections were washed three times for 20 min in 5× SSC at room temperature, 1 h in 0.5× SSC/20% formamide at 60°C, 15 min at 37°C in RNase buffer (0.5 M sodium chloride, 10 mM Tris-HCl pH 7, 5 mM EDTA) and treated with 10 mg/ ml RNase A for 30 min. After washes in RNase buffer for 15 min at 37°C, in 0.5× SSC/20% formamide for 30 min at 60°C and in 2× SSC for 30 min at room temperature, sections were blocked (1% blocking reagent (Boehringer Mannheim), 20% inactivated sheep serum in MABT) and incubated with anti-digoxygenin antibodies (Boehringer Mannheim) at a dilution of 1:5000 for 16-20 h at 4°C. Sections were washed five times for 10 min in TBST (140 mM sodium chloride, 2.7 mM potassium chloride, 25 mM Tris-HCl pH 7.5, 0.1% Tween 20), once for 10 min in NTMT (10 mM sodium chloride, 50 mM magnesium chloride, 100 mM Tris-HCl pH 9.5, 0.1% Tween 20), 10 min in TBST containing 2 mM levamisol and then developed for 1-5 days in BM-purple substrate (Boehringer Mannheim) containing 2 mM levamisol and 0.1% Tween 20. After staining sections were washed twice in NTMT for 15 min and 10 min in PBS. Slides were mounted in Kaisers glycerin gelatine (Merck) 
